Shares of OraSure Technologies Inc. (NASDAQ:OSUR) traded down 3.4% on Monday . The company traded as low as $6.23 and last traded at $6.24, with a volume of 205,828 shares. The stock had previously closed at $6.46.

A number of equities analysts recently issued reports on the stock. TheStreet lowered shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Friday, July 1st. BTIG Research reiterated a “buy” rating and issued a $8.00 target price on shares of OraSure Technologies in a research report on Tuesday, July 5th. Mizuho reiterated an “outperform” rating and issued a $8.00 target price on shares of OraSure Technologies in a research report on Tuesday, July 5th. Raymond James Financial Inc. lowered shares of OraSure Technologies from an “outperform” rating to a “market perform” rating and set a $8.00 target price for the company. in a research report on Monday, June 13th. Finally, Zacks Investment Research lowered shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Wednesday, May 25th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. OraSure Technologies has an average rating of “Buy” and a consensus target price of $8.08.

The firm’s 50-day moving average is $6.98 and its 200-day moving average is $6.71. The firm has a market capitalization of $356.20 million and a P/E ratio of 36.07.

OraSure Technologies (NASDAQ:OSUR) last released its quarterly earnings data on Wednesday, May 4th. The company reported $0.04 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.02. The company had revenue of $29.10 million for the quarter, compared to analysts’ expectations of $28.82 million. OraSure Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. Equities research analysts expect that OraSure Technologies Inc. will post $0.26 earnings per share for the current year.

A number of institutional investors have made changes to their positions in OSUR. Dimensional Fund Advisors LP boosted its position in shares of OraSure Technologies by 31.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 840,598 shares of the company’s stock worth $5,414,000 after buying an additional 199,049 shares during the last quarter. Morgan Stanley boosted its position in shares of OraSure Technologies by 40.9% in the fourth quarter. Morgan Stanley now owns 363,707 shares of the company’s stock worth $2,342,000 after buying an additional 105,627 shares during the last quarter. Oxford Asset Management acquired a new position in shares of OraSure Technologies during the fourth quarter worth about $1,209,000. Finally, American Century Companies Inc. acquired a new position in shares of OraSure Technologies during the fourth quarter worth about $1,371,000.

OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.